<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; } .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font20 { font-size : 20; } .font21 { font-size : 21; } .font22 { font-size : 22; } .font23 { font-size : 23; } .font24 { font-size : 24; } .font25 { font-size : 25; } .font26 { font-size : 26; } .font27 { font-size : 27; } .font30 { font-size : 30; } .font31 { font-size : 31; }</style>
 <body>
  <p>
   <span class="font31">participants </span>
   <span class="font30">(%) </span>
   <span class="font27">group </span>
   <span class="font26">responses </span>
   <span class="font26">MERS-CoV </span>
   <span class="font25">vaccine </span>
   <span class="font24">(·–·) </span>
   <span class="font23">study </span>
   <span class="font22">day </span>
   <span class="font21">low-dose </span>
   <span class="font20">adverse </span>
   <span class="font20">data </span>
   <span class="font20">high-dose </span>
   <span class="font19">MERS </span>
   <span class="font19">MVA-MERS-S </span>
   <span class="font19">antibodies </span>
   <span class="font19">events </span>
   <span class="font19">safety </span>
   <span class="font18">neutralising </span>
   <span class="font18">respiratory </span>
   <span class="font17">T-cell </span>
   <span class="font17">antibody </span>
   <span class="font17">East </span>
   <span class="font17">virus </span>
   <span class="font16">immune </span>
   <span class="font16">showed </span>
   <span class="font16">{border-style </span>
   <span class="font16">dose </span>
   <span class="font15">coronavirus </span>
   <span class="font15">px;} </span>
   <span class="font15">syndrome </span>
   <span class="font15">trial </span>
   <span class="font15">#ffffff;} </span>
   <span class="font15">days </span>
   <span class="font15">group) </span>
   <span class="font15">immunogenicity </span>
   <span class="font15">observed </span>
   <span class="font15">Day </span>
   <span class="font15">appendix </span>
   <span class="font15">phase </span>
   <span class="font14">MVA </span>
   <span class="font14">Middle </span>
   <span class="font14">neutralisation </span>
   <span class="font14">using </span>
   <span class="font14">ELISA </span>
   <span class="font14">[%] </span>
   <span class="font14">candidate </span>
   <span class="font14">immunisation </span>
   <span class="font14">positive </span>
   <span class="font14">spike </span>
   <span class="font14">figure </span>
   <span class="font14">prime </span>
   <span class="font14">viral </span>
   <span class="font13">development </span>
   <span class="font13">human </span>
   <span class="font13">infection </span>
   <span class="font13">number </span>
   <span class="font13">participant </span>
   <span class="font13">received </span>
   <span class="font13">vaccination </span>
   <span class="font13">vaccinia </span>
   <span class="font13">MERS-CoV-specific </span>
   <span class="font13">boost </span>
   <span class="font13">cells </span>
   <span class="font13">clinical </span>
   <span class="font13">group. </span>
   <span class="font13">immunity </span>
   <span class="font13">(n=) </span>
   <span class="font13">blood </span>
   <span class="font13">did </span>
   <span class="font13">disease </span>
   <span class="font13">mean </span>
   <span class="font13">reported </span>
   <span class="font13">severe </span>
   <span class="font13">test </span>
   <span class="font13">vaccine-induced </span>
   <span class="font13">value </span>
   <span class="font13">vector </span>
   <span class="font12">Infect </span>
   <span class="font12">PhD </span>
   <span class="font12">assay </span>
   <span class="font12">humoral </span>
   <span class="font12">local </span>
   <span class="font12">peptide </span>
   <span class="font12">profile </span>
   <span class="font12">protection </span>
   <span class="font12">protective </span>
   <span class="font12">spike-specific </span>
   <span class="font12">(day </span>
   <span class="font12">Dis </span>
   <span class="font12">animal </span>
   <span class="font12">available </span>
   <span class="font12">correlation </span>
   <span class="font12">density </span>
   <span class="font12">detected </span>
   <span class="font12">included </span>
   <span class="font12">including </span>
   <span class="font12">measured </span>
   <span class="font12">mouse </span>
   <span class="font12">prime–boost </span>
   <span class="font12">px; </span>
   <span class="font12">reduction </span>
   <span class="font12">response </span>
   <span class="font12">seven </span>
   <span class="font12">studies </span>
   <span class="font12">support </span>
   <span class="font12">table </span>
   <span class="font12">vaccinated </span>
   <span class="font12">{font-family </span>
   <span class="font12">(%; </span>
   <span class="font12">Ankara </span>
   <span class="font12">Center </span>
   <span class="font12">analysed </span>
   <span class="font12">antibodies. </span>
   <span class="font12">booster </span>
   <span class="font12">capacity </span>
   <span class="font12">cases </span>
   <span class="font12">cellular </span>
   <span class="font12">challenge </span>
   <span class="font12">dromedary </span>
   <span class="font12">following </span>
   <span class="font12">font-size </span>
   <span class="font12">group, </span>
   <span class="font12">high </span>
   <span class="font12">induced </span>
   <span class="font12">modified </span>
   <span class="font12">reciprocal </span>
   <span class="font12">research </span>
   <span class="font12">role </span>
   <span class="font12">second </span>
   <span class="font12">sera </span>
   <span class="font12">similar </span>
   <span class="font12">systemic </span>
   <span class="font12">titre </span>
   <span class="font11">CD, </span>
   <span class="font11">CI) </span>
   <span class="font11">Clinical </span>
   <span class="font11">DNA </span>
   <span class="font11">Elsevier </span>
   <span class="font11">Geometric </span>
   <span class="font11">MMA </span>
   <span class="font11">PBMCs </span>
   <span class="font11">TK, </span>
   <span class="font11">analyses </span>
   <span class="font11">baseline </span>
   <span class="font11">binding </span>
   <span class="font11">considered </span>
   <span class="font11">crucial </span>
   <span class="font11">demonstrated </span>
   <span class="font11">detectable </span>
   <span class="font11">double; </span>
   <span class="font11">event </span>
   <span class="font11">events. </span>
   <span class="font11">follow-up </span>
   <span class="font11">glycoprotein </span>
   <span class="font11">healthy </span>
   <span class="font11">induction </span>
   <span class="font11">million </span>
   <span class="font11">optical </span>
   <span class="font11">participants, </span>
   <span class="font11">pools </span>
   <span class="font11">shown </span>
   <span class="font11">significant </span>
   <span class="font11">single </span>
   <span class="font11">solicited </span>
   <span class="font11">strong </span>
   <span class="font11">trials. </span>
   <span class="font11">vaccines </span>
   <span class="font11">values </span>
   <span class="font11">AF, </span>
   <span class="font11">Data </span>
   <span class="font11">Figure </span>
   <span class="font11">Lancet </span>
   <span class="font11">MVA-MERS-S, </span>
   <span class="font11">Medical </span>
   <span class="font11">PRNT </span>
   <span class="font11">Participants </span>
   <span class="font11">Prof </span>
   <span class="font11">S-specific </span>
   <span class="font11">SFCs </span>
   <span class="font11">Safety </span>
   <span class="font11">Sci </span>
   <span class="font11">acute </span>
   <span class="font11">additional </span>
   <span class="font11">analysis. </span>
   <span class="font11">assessed </span>
   <span class="font11">border-color </span>
   <span class="font11">border-width </span>
   <span class="font11">centre </span>
   <span class="font11">completed </span>
   <span class="font11">control </span>
   <span class="font11">defined </span>
   <span class="font11">doses </span>
   <span class="font11">evaluated </span>
   <span class="font11">experiments </span>
   <span class="font11">favourable </span>
   <span class="font11">future </span>
   <span class="font11">groups </span>
   <span class="font11">identical </span>
   <span class="font11">immunisation, </span>
   <span class="font11">immunisation. </span>
   <span class="font11">individuals </span>
   <span class="font11">mice </span>
   <span class="font11">novel </span>
   <span class="font11">outbreak </span>
   <span class="font11">pool </span>
   <span class="font11">potential </span>
   <span class="font11">provided </span>
   <span class="font11">responses. </span>
   <span class="font11">revealed </span>
   <span class="font11">solid; </span>
   <span class="font11">testing </span>
   <span class="font11">timepoint </span>
   <span class="font11">{font-style </span>
   <span class="font11">{font-weight </span>
   <span class="font11"> ×  </span>
   <span class="font11">–). </span>
   <span class="font11">(·) </span>
   <span class="font11">(·; </span>
   <span class="font11">(–) </span>
   <span class="font11">AK, </span>
   <span class="font11">Adverse </span>
   <span class="font11">Ankara. </span>
   <span class="font11">BLH, </span>
   <span class="font11">COVID- </span>
   <span class="font11">DZIF </span>
   <span class="font11">Following </span>
   <span class="font11">GS, </span>
   <span class="font11">Germany) </span>
   <span class="font11">Germany). </span>
   <span class="font11">IFNγ </span>
   <span class="font11">MERS-CoV. </span>
   <span class="font11">MVA-specific </span>
   <span class="font11">MVA=modified </span>
   <span class="font11">NMAO, </span>
   <span class="font11">S=spike. </span>
   <span class="font11">SBo, </span>
   <span class="font11">Saudi </span>
   <span class="font11">Seropositivity </span>
   <span class="font11">VK, </span>
   <span class="font11">Virol </span>
   <span class="font11">Zhao </span>
   <span class="font11">analysis </span>
   <span class="font11">bold </span>
   <span class="font11">breadth </span>
   <span class="font11">camels </span>
   <span class="font11">cells. </span>
   <span class="font11">cohorts </span>
   <span class="font11">common </span>
   <span class="font11">coronavirus. </span>
   <span class="font11">courier; </span>
   <span class="font11">daily </span>
   <span class="font11">determined </span>
   <span class="font11">efficacy </span>
   <span class="font11">em; </span>
   <span class="font11">evaluate </span>
   <span class="font11">evidence </span>
   <span class="font11">exact </span>
   <span class="font11">experienced </span>
   <span class="font11">funding </span>
   <span class="font11">health </span>
   <span class="font11">homologous </span>
   <span class="font11">horizontal </span>
   <span class="font11">investigated </span>
   <span class="font11">larger </span>
   <span class="font11">line </span>
   <span class="font11">majority </span>
   <span class="font11">monoclonal </span>
   <span class="font11">multiple </span>
   <span class="font11">occurrence </span>
   <span class="font11">open-label, </span>
   <span class="font11">overlapping </span>
   <span class="font11">participants. </span>
   <span class="font11">post-hoc </span>
   <span class="font11">predominantly </span>
   <span class="font11">primary </span>
   <span class="font11">protein </span>
   <span class="font11">pt;} </span>
   <span class="font11">reactogenicity </span>
   <span class="font11">remains </span>
   <span class="font11">resource </span>
   <span class="font11">responses, </span>
   <span class="font11">results </span>
   <span class="font11">samples </span>
   <span class="font11">shown). </span>
   <span class="font11">study, </span>
   <span class="font11">study. </span>
   <span class="font11">symptom </span>
   <span class="font11">tested </span>
   <span class="font11">tolerability </span>
   <span class="font11">vaccination, </span>
   <span class="font11">visit </span>
  </p>
 </body>
</html>
